News Focus
News Focus
Followers 59
Posts 7595
Boards Moderated 0
Alias Born 10/20/2014

Re: Number sleven post# 419193

Friday, 12/15/2023 10:46:05 PM

Friday, December 15, 2023 10:46:05 PM

Post# of 448162
I doubt if that will happen because I believe GIA is suicide.
Denner believes in fixing broken companies and then selling
them off. Now Denner obviously will do what he can to induce
sales, especially in Europe. But I still believe that a Eurocentric
BC (such as Bayer or AZN) would be best suited to optimize
uptake of Vazkepa in Europe and logically, I believe that AD
sees it that way as well. Remember, AZN could have bought
out AMRN well before Reduce-It results were out. Instead,
they acquired a public company that had an inferior drug candidate.
Stupid of AZN to have not bought AMRN at that time
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News